Gerresheimer (GXI) Given a €55.00 Price Target by Hauck & Aufhaeuser Analysts

Hauck & Aufhaeuser set a €55.00 ($65.48) target price on Gerresheimer (ETR:GXI) in a research report report published on Thursday morning. The firm currently has a sell rating on the stock.

Other analysts also recently issued research reports about the company. Commerzbank set a €77.00 ($91.67) target price on Gerresheimer and gave the stock a buy rating in a research note on Thursday, September 28th. JPMorgan Chase & Co. set a €99.40 ($118.33) price target on Gerresheimer and gave the stock a buy rating in a report on Wednesday, October 11th. Berenberg Bank set a €75.00 ($89.29) price target on Gerresheimer and gave the stock a buy rating in a report on Wednesday, October 11th. Credit Suisse Group set a €80.00 ($95.24) price target on Gerresheimer and gave the stock a buy rating in a report on Tuesday, October 10th. Finally, set a €65.00 ($77.38) price target on Gerresheimer and gave the stock a neutral rating in a report on Tuesday, October 17th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the stock. Gerresheimer has a consensus rating of Hold and a consensus price target of €71.02 ($84.55).

Shares of Gerresheimer (GXI) traded up €0.30 ($0.36) on Thursday, hitting €71.45 ($85.06). The stock had a trading volume of 104,674 shares, compared to its average volume of 110,116. Gerresheimer has a 1 year low of €59.97 ($71.39) and a 1 year high of €78.25 ($93.15). The stock has a market capitalization of $2,240.00 and a P/E ratio of 50.67.

TRADEMARK VIOLATION NOTICE: “Gerresheimer (GXI) Given a €55.00 Price Target by Hauck & Aufhaeuser Analysts” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3146666/gerresheimer-gxi-given-a-55-00-price-target-by-hauck-aufhaeuser-analysts-2.html.

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.